FTC Challenges FDA, Transparency re Dug Prices, Fems vs Addyi, A Scene at Pharma
'Welcome to Pharma Industry News Update (aka PinUp), which is published every two weeks as part of the Pharma Marketing News subscription service. PinUp presents selected content from previous issues of Pharma Marketing News as well as curated content of topical interest from a variety of other sources.
Will the REAL Nexium Facebook Page Please Stand Up?
My friend Zoe Dunn (@zdunnhealth), a digital marketing consultant to the pharma industry, wrote a piece in MM&M titled “Is It Finally Time for Pharma...
Social Media Lacks the “Ask Your Doctor” ROI Common for Print & TV DTC...
Practically every print and TV direct-to-consumer (DTC) ad prominently includes the statement "Ask Your Doctor if is Right for You!"
Advertisers call this the...
The Power of Patient Input: How FDA Learned to Love & Approve Addyi
This article presents a case study of how patient input has the power to change the course of drug approval. The case is Sprout's ground-breaking patient campaign that played a major role in getting Addyi, a female sexual dysfunction drug, approved by the FDA.
Celebrities + Social Media: Balancing Benefits and Risks
This article focuses on the risks and benefits of using celebrities and social media to promote pharma brands and proposes that it may be time for the pharma industry to disclose the details of payments made to celebrities as they now are required to do for physician payments.
Pharma’s Use of Medical Conference Twitter Hashtags: Is It “Backchannel” Promotion That Needs to...
This article discusses the pros and cons of safeguards proposed a group of academic physicians (the #MICEproject) to limit pharmaceutical 'detailing' and to 'bring the medical community closer to establishing guidelines for third party activities in Twitter back-channels.'
Pharma Marketing News Vol. 14, No. 6: September 2015
Welcome to Vol. 14, Issue No. 6 (SEPTEMBER 2015) of Pharma Marketing News. Medical conference hashtags, celebrities + social media, and Patient Power are the themes of this issue.
Boehringer Ingelheim Supports Undocumented Immigrants & Sides with Latino TV vs. Donald Trump. Bravo!
Click on image for an enlarged, uglier view.
Two stories caught my attention yesterday:
One involved drug company Boehringer Ingelheim and Spanish-language television network Telemundo.
The other...
FDA Acts on Violative Social Media Posts a Lot More Quickly Than It Does...
Kim Kardashian posted a violative Diclegis® ad on Instagram (read “Kim Kardashian's Diclegis Instagram Post Raises Issues of Transparency, Drug Safety, and Learning from...
The Irrelevance of Social Media for Pharma Marketing
The pharmaceutical industry has often been criticized for being behind the "digital curve," meaning that it lacks the expertise to fully take advantage of...
